0000-0003-2228-4094 Employment
-
Duke University
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Alirocumab plus cemiplimab in immuno-refractory metastatic NSCLC: A single-arm, multi-center, phase 2 study. Save
- Assessing the impact of PCSK9 inhibition in small cell lung cancer with novel DLL3-targeted bispecific T-cell engager therapy. Save
- Feasibility assessment of a global, anonymized, human-in-the-loop AI decision-support platform for oncology second opinions following a live demo at an international symposium. Save
- Broadening clinical trial inclusivity of patients with lung cancer and brain metastases utilizing the Graded Prognostic Assessment (GPA): A call to action Save
- CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia. Save
- Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States. Save
- Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer. Save
- A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS Save
- Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States Save
- SCLC Outcomes and Real-World Insight with Tarlatamab, a Multi-Center Experience Save